Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

(2011) Runbo Zhong et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Melanoma drug wins US approval

(2011) Heidi Ledford   NATURE

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells

(2011) Xiang Huang   WORLD JOURNAL OF GASTROENTEROLOGY

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

(2010) Suzanne Ostrand-Rosenberg   CANCER IMMUNOLOGY IMMUNOTHERAPY

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity

(2010) J. Vincent et al.   CANCER RESEARCH

Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

(2009) Hwan Mook Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination

(2009) Mohamed Labib Salem et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

(2009) Vedran Radojcic et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo

(2009) Mohamed L. Salem et al.   CELLULAR IMMUNOLOGY

Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine

(2009) H.-J. Ko et al.   JOURNAL OF IMMUNOLOGY

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

(2008) R. Nishimura et al.   BLOOD

Melanoma epidemiology and trends

(2008) Claus Garbe et al.   CLINICS IN DERMATOLOGY

Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model

(2008) Hwan Mook Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Orchestrating the orchestrators: chemokines in control of T cell traffic

(2008) Shannon K Bromley et al.   NATURE IMMUNOLOGY

Cancer Immunology

(2008) Olivera J. Finn   NEW ENGLAND JOURNAL OF MEDICINE